Thema
Letter
Comment
7.202
COVID-19
3.102
Research Support, Non-U.S. Gov't
1.444
Case Reports
1.315
COVID-19 Vaccines
1.052
SARS-CoV-2
1.020
Antibodies, Viral
459
Antiviral Agents
388
Hydroxychloroquine
350
4QWG6N8QKH
347
Research Support, N.I.H., Extramural
343
RNA, Viral
278
Angiotensin-Converting Enzyme 2
232
EC 3.4.17.23
232
Coronavirus
215
Biomarkers
202
BNT162 Vaccine
196
N38TVC63NU
195
Anticoagulants
194
Spike Glycoprotein, Coronavirus
193
Antibodies, Monoclonal, Humanized
191
ACE2 protein, human
187
EC 3.4.15.1
181
Observational Study
181
Peptidyl-Dipeptidase A
181
coronavirus
180
Immunoglobulin G
174
Covid-19
171
Review
159
Multicenter Study
152
Aerosols
148
Pandemic
141
Clinical Trial Protocol
138
Cytokines
136
spike protein, SARS-CoV-2
132
Immunosuppressive Agents
128
Antibodies, Neutralizing
126
RNA, Messenger
125
83905-01-5
123
Azithromycin
123
Comparative Study
119
Anti-Bacterial Agents
118
Vaccines
114
Adrenal Cortex Hormones
112
tocilizumab
110
I031V2H011
109
epidemiology
96
Randomised controlled trial
95
protocol
95
mehr ...